Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
gap & trap, then grind & fade all day
sigh
Chaotic trading!
AKTX Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
https://www.tradescores.com/StockReport/aktx
It appears that the board here went dead. Any recent thoughts on this stock?
* * $AKTX Video Chart 04-23-2019 * *
Link to Video - click here to watch the technical chart video
You obviously cant read a filing.
Yes my friend it was! Patience paid off for us! God Bless u and yours! MBD
MBD, it was quite the struggle but grateful we remained patient. It was strange seeing all these new posters here all of a sudden. I made a few great trades, and have just starting grabbing a few shares back. I live here in Vancouver and will be attending the eye conference next month.
I guess this one is headed to the billion
Share mark
Wow company has 158.1 million shares
Just announced that they will issue 445 million more shares.
Very bad news for share holders.
Expect Aktx to tank and hard at the open.
Next week 1.40 per share and that's if aktx is lucky.
Looks like Aktx is going to issue a ton of shares to raise money. They just filed with the SEC at 4.11 pm afterhours explains the big drop.
Tomorrow earnings hit premarket.
Premarket earnings in the am before market opens on Tuesday..
Panic setting in down on very very little volume.
I got shares and they are for sale.
$32.00 on fda approval ....
Thank you, that's nice of you.
I have an eye on this one again, just watching it.
$AKTX Positive FDA meeting outlines path ahead for Coversin in hematopoietic stem cell Transplant-related thrombotic microangiopathy
That was weds and it did.You lose again.
* * $AKTX Video Chart 03-14-2019 * *
Link to Video - click here to watch the technical chart video
NVAX I bought 6000 shares
checking and what i thought you don't know jack shit...
Good luck to you, I'll look into NVAX again.
Sold AKTX for $7.90 earlier today. Still in ATOS from $4.73.
Will look into NVAX again.
Did you get in any? Let me know.
Atos won’t do the same play as Atkx am all in nvax hoping for a nice run
Yeah got in AKTX again yesterday after market.
I've been watching nvax and had a bid on it this morning, then got into ATOS instead.
Nvax is next . shorts loaded too much. Squeeze coming .
should be no offering with shelf in place
No offering so far, looks ripe for a run to $10 plus
I wouldn’t short you will get squeezed at open...
Lol what a lame excuse
*NXTD Everybody STRONG BUY/HOLD!! Not spamming this board, couldn't find a NXTD board!! Will not post again about NXTD on this board! MBD
Has to test $11.50 that's where the resistance is, provided no offering in place
feels like $10+ coming
but Im not taking the risk
not after BPTHurd
good for you SmarMoney, I like you, you are a good individual.
AMEN MY BROTHER!!!!!!!! YES I WILL BE TITHING!! 100K!! PRAISE GOD ALMIGHTY!!! ALL OUT AT $9.50!! MBD
hope it does,......
I sold 9.17
AKTX
I got ripped on BPTH offering
The surge @ opening bell will set off Nasdaq circuit breakers. Halts likely.
WOW YOU MADE A MILLION DOLLARS.... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147508470
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147527120
CONGRAT$
thats $100k tithe
what are you going to do with the rest?
hopefully open up a Church
and stop gambling out here
I've seen them happened cause I was part of the run too.
AKTX > $15. to $20.+ range > momo + fomo + huge vol. With this super low float.
Seen it happen many times with bio-pharmas.
Followers
|
13
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
552
|
Created
|
09/21/15
|
Type
|
Free
|
Moderators |
Akari is focused on developing inhibitors of acute and chronic inflammation, specifically the complement system, and leukotriene system,
for the treatment of rare and orphan diseases with unmet need. We believe that blocking early mediators of inflammation
will prevent initiation and continual amplification of the processes that cause certain diseases.
Nomacopan is a recombinant small protein (16,740 Da) that acts on complement component-C5,
preventing release of C5a and formation of C5b–9 (also known as the membrane attack complex, or MAC),
and independently also inhibits leukotriene B4, or LTB4, activity, both elements that are co-located as part of the immune/inflammatory response.
Nomacopan is currently being clinically evaluated in four indications:
Akari believes that the dual action of nomacopan on both C5 and LTB4 may be beneficial in AKC, BP, and aHUS. Akari is also developing other tick derived proteins, including longer acting versions.
Nomacopan is a highly soluble and stable biological molecule, and independently binds to both C5 and LTB4. This novel dual binding enables targeting of two distinct and separate disease categories based on their underlying etiology.
July 1, 2020
July 1, 2020
June 1, 2020
May 1, 2020
March 31, 2020
Patients with COVID-19 pneumonia
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |